ExodusPoint Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
VPM
VCM
RRAM
ExodusPoint Capital Management's HAE Position: Q1 2026 in Review
ExodusPoint Capital Management reduced its Haemonetics (HAE) stake by 50% in Q1 2026, selling an estimated $3.16M and leaving 47,750 shares worth $2.69M. The position accounts for 0.02% of the portfolio, ranked #655.
ExodusPoint Capital Management first reported a position in HAE in Q4 2019 and has held it in 17 quarters since. The position peaked at $15.2M in Q3 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- ExodusPoint Capital Management held 47,750 shares of Haemonetics worth $2.69M as of Q1 2026.
- ExodusPoint Capital Management sold 48,568 Haemonetics shares in Q1 2026, an estimated $3.16M.
- Haemonetics made up 0.02% of ExodusPoint Capital Management's portfolio in Q1 2026, its #655 holding.
- ExodusPoint Capital Management first reported a position in Haemonetics in Q4 2019 and has held it in 17 quarters since.
- ExodusPoint Capital Management's Haemonetics position peaked at $15.2M in Q3 2025.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.